Lumiera Health Inc.
Other OTCTotal Valuation
Lumiera Health Inc. carries a market capitalization of 3.03M, placing it among publicly traded companies globally. Its enterprise value stands at 1.31M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.03M |
| Enterprise Value | 1.31M |
Share Statistics
Lumiera Health Inc. currently has 169.97M shares outstanding.
| Shares Outstanding | 169.97M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 3.02 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 20.12 |
Financial Position
Lumiera Health Inc. maintains a current ratio of 0.09, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -77.93, indicating conservative leverage, while an interest coverage ratio of -1.22 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.09 |
| Quick Ratio | 0.03 |
| Debt / Equity | -77.93 |
| Debt / EBITDA | -2.56 |
| Interest Coverage | -1.22 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -202.92 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.13 |
Stock Price Statistics
Lumiera Health Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -516,760.00, while operating income came in at -548,914.00.
| Revenue | 433,294.00 |
| Gross Profit | 57,077.00 |
| Operating Income | -548,914.00 |
| Pretax Income | -1.73M |
| Net Income | -1.73M |
| EBITDA | -516,760.00 |
| EBIT | -548,914.00 |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Lumiera Health Inc. holds 12,699.00 in cash and equivalents against 1.32M in total debt, resulting in a net debt position of 1.31M. Total book value stands at -4.90M, with working capital of -1.41M providing operational flexibility.
| Cash & Cash Equivalents | 12,699.00 |
| Total Debt | 1.32M |
| Net Debt | 1.31M |
| Equity (Book Value) | -4.90M |
| Book Value Per Share | N/A |
| Working Capital | -1.41M |
Cash Flow
Lumiera Health Inc. produced -359,296.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -359,296.00 |
| Capital Expenditures | -1.00 |
| Free Cash Flow | -359,297.00 |
| FCF Per Share | N/A |
Margins
Lumiera Health Inc. operates with a gross margin of 13.17, reflecting its pricing power and cost economics. The operating margin of -126.68 and net profit margin of -398.18 provide insight into operational efficiency.
| Gross Margin | 13.17 |
| Operating Margin | -126.68 |
| Pretax Margin | -398.18 |
| Profit Margin | -398.18 |
| EBITDA Margin | -119.26 |
Scores
Lumiera Health Inc. posts an Altman Z-Score of -117.75, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -117.75 |